SEVA Devices was co-founded by Denny Durmis and Rakesh Amin to address a structural inefficiency in the U.S. radiology disposables market. The major OEMs, Bayer, Bracco, Guerbet, GE, and Nemoto, have progressively driven customers toward proprietary platforms and bundled contracts that tie injector disposables to contrast media purchases. The clinical performance of the disposables themselves is largely equivalent across generations. The commercial terms are not.
The phrase "alternative source" is retired from all SEVA materials. SEVA is not in that category.
SEVA's structural advantage is manufacturing pedigree. SEVA products are produced by the same global contract manufacturer that supplies a major European manufacturer of injector consumables and disposables. This is materially different from competitors in the so-called alternative source category, which compete primarily on price without comparable manufacturer credentials. SEVA is not in that category and is not marketed as such.
The business sells direct. Contracts with imaging centers, hospitals, and IDNs are written without distributor layers, without contrast media requirements, and without the proprietary lock-ins that follow every Bayer, Bracco, or Guerbet capital upgrade. GPO access is available through HPG, with Premier in progress. All customer service stays SEVA-branded regardless of the contracting channel.
SEVA currently operates in the U.S. market. European expansion is planned, with timing to be confirmed. The site and operational infrastructure are built to support international customers without structural rework.